Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women

American Journal of Obstetrics and Gynecology

Volumn 184, Issue 3, 2001, Pages 382-389

  Bombeli, Thomas ^a   Raddatz Mueller, Pascale ^a   Fehr, Joerg ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Coagulation activation markers; Pregnancy; Thrombophilia; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ANTICOAGULATION; ARTICLE; COMPLEX FORMATION; FEMALE; HEPARINIZATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS;

EID: 0035089761     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2001.109397     Document Type: Article

References (25)

1. Obstetrical pulmonary embolism mortality: United States 1970-85
2. Thrombotic risk during pregnancy and puerperium in women with APC-resistance: Effective subcutaneous heparin prophylaxis in a pregnant patient
3. Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C, protein S
4. Thrombosis and pregnancy in congenital deficiencies of AT III, protein C, or protein S: Study of 78 women
5. Recurrence of venous thromboembolic disease and use of oral contraceptives
6. The British Society for Heamatology guidelines on the use and monitoring of heparin, 1992. 2nd rev.
7. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: An overview
8. D-Dimer strategy in thrombosis exclusion
9. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery
10. Markers of hypercoagulability in cancer patients
11. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia
12. Activated protein C: alpha-1-antitrypsin (APC:alpha-1-AT) complex as a marker for in vitro diagnosis of prethrombotic states
13. Maternal plasma D-dimer levels in normal and complicated pregnancies
14. Complications in HELLP syndrome due to peripartal hemostatic disorder
15. Prothrombin activation fragment (F1.2) is increased in pregnant patients with antiphospholipid antibodies
16. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies
17. Antiphospholipid antibodies as a cause of immunologic thrombopenia and thrombopathies
18. Prevention of venous thromboembolism with heparin in risk patients during pregnancy: Monitoting by measuring thrombin-antithrombin III complex
19. Levels of coagulation inhibitors and thrombin-antithrombin III complexes in normal pregnancy
20. Generation of thrombin in blood plasma of nonpregnant and pregnant women studied through concentration of thrombin-antithrombin III complexes
21. D-Dimer plasma measurement in patients undergoing major hip surgery: Use in the prediction and diagnosis of postoperative proximal vein thrombosis
22. D-Dimers, thrombin-antithrombin-III complexes (TAT), aud prothrombin fragment 1.2 (PTF): Parameters for monitoring therapy of low-molecular-weight heparin in coagulation disorders
23. Laboratory monitoring of thromboprophylaxis with low molecular weight and standard heparin
24. Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery: A meta-analysis